FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria FDA OKs Cetirizine Injection (Quzyttir) for Acute Urticaria

Cetirizine hydrochloride (10 mg/mL) intravenous injection is for treatment of acute urticaria in adults and children 6 months of age or older.FDA Approvals

Source: Medscape Internal Medicine Headlines - October 15, 2019 Category: Internal Medicine Tags: Dermatology News Alert Source Type: news